Inflammatory Breast Cancer
Symptoms, Doctors, Treatments, Advances & More

Inflammatory Breast Cancer Overview

Save information for later
Sign Up

Learn About Inflammatory Breast Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Inflammatory Breast Cancer Local Doctors?
Elite in Inflammatory Breast Cancer
Oncology | Hematology Oncology
Elite in Inflammatory Breast Cancer
Oncology | Hematology Oncology

Yale University

35 Park St, 
New Haven, CT 
Languages Spoken:
English

Eric Winer is an Oncologist and a Hematologist Oncology provider practicing medicine in New Haven, Connecticut. Dr. Winer is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.

Elite in Inflammatory Breast Cancer
Surgical Oncology | General Surgery
Elite in Inflammatory Breast Cancer
Surgical Oncology | General Surgery

Brigham And Women's Hospital, Division Of Breast Surgery

75 Francis Street, 
Boston, MA 
Languages Spoken:
English

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Nakhlis is board certified in Surgery, General.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Inflammatory Breast Cancer
Elite in Inflammatory Breast Cancer

Dana-Farber Cancer Institute, Breast Oncology Program

450 Brookline Avenue, Susan F. Smith Center For Women's Cancers, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Lynce is board certified in Medical Oncology.

What are the latest Inflammatory Breast Cancer Clinical Trials?
Inflammatory Breast Cancer (IBC) Registry

Summary: This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing samples of blood, tissue, and stool from patients with inflammatory breast cancer to study in the laboratory may help doctors find better ways to treat and study inflammatory breast cancer in the future.

Match to trials
Find the right clinical trials for you in under a minute
Get started